Cancer, Advanced Completed Phase 1 Trials for Temsirolimus (DB06287)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

DBCOND0041606 (Cancer, Advanced)Completed1 IdentifierTitlePurposeDrugs
NCT00761644Doxil, Bevacizumab and Temsirolimus TrialTreatment
NCT00610493Bevacizumab and Temsirolimus in Patients With Advanced MalignancyTreatment
NCT00770731Study of Temsirolimus, Topotecan, and BortezomibTreatment